Highlights the structural defects in LPL genes causing type I hyperlipidemia and the potential for characterizing functional sites using the 3D structure of related lipases.
Answers are grounded in this paper and cite their sources.
Structural insights into LPL deficiency remain incomplete; leaves open precise catalytic site mapping pending 3D lipase structures.
With the detailed knowledge of the primary structure of lipoprotein lipase (LPL) which has been gained from complementary DNA clones, investigation has concentrated on structural defects in the genes of patients with LPL deficiency (type I hyperlipidemia), along with corresponding defects in the LPL protein. The recent description of the three-dimensional structure of a related lipase, human pancreatic lipase, will undoubtedly lead to a precise characterization of the sites on the LPL and hepatic lipase proteins that confer catalytic activity, heparin binding, lipid binding and other features.
No takes yet. Share an insight, caveat, or question.
Philip A. Kern (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: